(HealthDay): Bronchodilator therapy for the treatment of bronchiolitis in infants decreased significantly from 2010 to 2018, according to a study published online July 6 in Pediatrics.
Kristen H. Shanahan, MD, of Boston Children’s Hospital, and colleagues evaluated the trends and outcomes associated with the use of bronchodilators for bronchiolitis. Use from 2010 to 2018 data since 49 childrenin hospitals, the authors reviewed 446,696 visits to the emergency department babies (
The researchers found that the use of bronchodilator, hospital admission and return visits to the emergency service decreased during the study period. However, admission to the intensive care unit and invasive and non-invasive ventilation increased during the study period. Early use of the bronchodilator at the hospital level (high and low utilization) was not associated with differences in patient-level hospital admission, admission to the intensive care unit, return visits to emergency services , non-invasive ventilation or invasive ventilation.
“This study supports the current recommendation of the American Academy of Pediatrics to limit the routine use of bronchodilators in infants with bronchiolitis,” the authors write. “A future study may define a subgroup of babies with bronchiolitis who respond to bronchodilators.”
Summary / Full text (subscription or payment may be required)
Copyright © 2021 HealthDay. All rights reserved.
Citation: Use of bronchodilators for the treatment of bronchiolitis in infants (2021, July 6) retrieved July 6, 2021 at https://medicalxpress.com/news/2021-07-bronchodilators-bronchiolitis-treatment-infants.html
This document is subject to copyright. Apart from any fair treatment for the purposes of private study or research, no part may be reproduced without written permission. Content is provided for informational purposes only.